Drug recall D-0290-2025
Product
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.
Reason for recall
Super-Potent Drug: Out of specification potency results were obtained.
Lots and codes
Lot 3116074, Exp. 09/30/2025
Recall details
- Recalling firm
- Mylan Institutional, Inc., Rockford, IL
- Quantity
- 347 Cartons
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 7, 2025
Related products
- Levothyroxine Sodium – drug information
- NDC 51079-442 Levothyroxine Sodium · Levothyroxine Sodium 100 ug/1 · Mylan Institutional Inc.
- NDC 51079-445 Levothyroxine Sodium · Levothyroxine Sodium 150 ug/1 · Mylan Institutional Inc.
- NDC 51079-444 Levothyroxine Sodium · Levothyroxine Sodium 25 ug/1 · Mylan Institutional Inc.
- NDC 51079-440 Levothyroxine Sodium · Levothyroxine Sodium 50 ug/1 · Mylan Institutional Inc.
- NDC 51079-441 Levothyroxine Sodium · Levothyroxine Sodium 75 ug/1 · Mylan Institutional Inc.
- NDC 51079-443 Levothyroxine Sodium · Levothyroxine Sodium 125 ug/1 · Mylan Institutional Inc.